Hopefully, the identification of other novel natural products that significantly modulate insulin and/or pdx1 promoter activity will point to new methods of controlling beta-cell function and fate and eventually to new diabetes therapeutics based on the lead structures of these natural products. This evidence concerns the gene INS and diabetes mellitus.